Possible Ventures
VC Fund
Munich, Germany
Possible Ventures is a VC fund in Munich focused on Software and Information Technology. Possible Ventures backs ambitious teams building frontier technology to positively impact people and the planet. We invest in the early stages, actively supporting founders via our collective of global entrepreneurs.We're unabashed optimists when it comes to the power of technology to solve problems. And we invest our time and capital tohelp make innovation possible.We’re excited by technology ecosystems that are changing our future: the combination of AI, robotics and satellites that helps build new climate solutions and food systems; the convergence of blockchain and cryptocurrencies making decentralised finance possible; and new technologies like machine learning, genetic modification and synthetic biology that are enabling human health breakthroughs.We've harnessed the experience and networks of a global collective of entrepreneurs. Together, we discover and support great companies aligned with our mission. This armada of angels gives time and capital to 'pay it forward' to the next generation of founders in pursuit of a better world.We started this mission as Inventures. Our name has changed, but our collective approach and microfund strategy remain the same. We're redefining what's Possible.
- Total investments:
- 171
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Possible Ventures invests in
Stages Possible Ventures invests in
Countries Possible Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.5M–$10M
- Pre-Seed
- $586k–$3.5M
- Series A
- $9.7M–$47M
Investment Focus
Industry
- Software 37 (22%)
- Information Technology 14 (8%)
- Biotechnology 13 (8%)
- Artificial Intelligence 13 (8%)
- Health Care 11 (6%)
Stage
- Seed 69 (40%)
- Pre-Seed 44 (26%)
- Series A 23 (13%)
- Series B 10 (6%)
- Funding Round 5 (3%)
Country
- Germany 38 (22%)
- United States 23 (13%)
- Australia 21 (12%)
- United Kingdom 16 (9%)
- France 4 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chris Hitchen
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 42 | Find email | |
Christoph Baumeister
Partner
|
Partner | Total investments: 18 | Find email | |
Tim Linnenweber
Senior Associate
|
Senior Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines. | $3.4M / Pre-Seed / Jun 23, 2026 | ||
| Orbem is shedding light on the world's toughest challenges by unleashing AI-powered imaging for everything and everyone. This means developing fast, accurate, and accessible imaging solutions that provide access to otherwise unattainable sources of knowledge.Orbem is developing deep tech solutions to sustainably feed the world, improve humanhealth, and maximize human potential.Based on years of scientific research at the interface of AI and imaging technology, Orbem was founded in 2019 as a spin-off from the Technical University of Munich. | $64.6M / Series B / Jan 20, 2026 | ||
| Transition Biomining is a metal ore mining technology company that offers data driven solutions for copper extraction and mining. | $6M / Seed / Jan 15, 2026 | ||
| Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology. | $10M / Seed / Nov 03, 2025 | ||
| Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows. | $65M / Series B / Oct 06, 2025 | ||
| Telura is a deep-tech business that uses next-generation drilling to enable geothermal energy everywhere. Telura creates electric impulse drilling technology, which breaks rock from within using high-voltage pulses. | $4.7M / Pre-Seed / Oct 01, 2025 | ||
| material technology to seperate gases | $8.2M / Seed / Sep 25, 2025 | ||
| SWARM Biotactics creates fully controllable bio-robotic systems for defense, national security, disaster recovery, and industrial inspection. SWARM provides real-time data from the world's most remote locations by merging biology, edge AI, swarm intelligence, and secure communications. | $11.6M / Seed / Jun 24, 2025 | ||
| ViridiCO2 has invented a radical solution with the creation of technology that converts waste carbon dioxide into high-value chemical products such as surfactants, polymer feedstocks, and small molecules. To achieve this, the company converts carbon dioxide (CO2) into a range of highly valuable chemical intermediates. By substituting waste CO2directly for petrochemicals, ViridiCO2's patented technology lowers the amount of energy needed to power the manufacturing process. | Seed / May 20, 2025 | ||
| Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows. | $16.6M / Series A / Mar 03, 2025 | ||
| See all 171 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Possible Ventures invest in?
Possible Ventures invests primarily in Software, Information Technology and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 171 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Possible Ventures's check size?
Possible Ventures typically joins rounds of $1.5M–$10M at Seed, $586k–$3.5M at Pre-Seed and $9.7M–$47M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Possible Ventures participates in.
How do I contact Possible Ventures?
Public channels for Possible Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Possible Ventures?
The team at Possible Ventures includes Chris Hitchen (Founder and Managing Partner), Christoph Baumeister (Partner) and Tim Linnenweber (Senior Associate). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
